NCT04696757View on ClinicalTrials.gov

Non-OpeRative MANagement of Rectal Cancer Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Rectal CancerChemoradiotherapyWatch & Wait
Interventions
DRUG

Capecitabine

Capecitabine without surgery

Trial Locations (1)

110-746

Kangbuk Samsung Hospital, Seoul

All Listed Sponsors
lead

Kangbuk Samsung Hospital

OTHER

NCT04696757 - Non-OpeRative MANagement of Rectal Cancer Patients | Biotech Hunter | Biotech Hunter